Industry

Commercially Available Nutraceutical Developed by Phase III Stem Cell Biotechnology Company Continues to Receive Independent Validation of Potential Benefit in SARS-CoV-2 Strains OCEANSIDE, Calif.–(BUSINESS WIRE)–Therapeutic Solutions International, a clinical-stage biotechnology company, commented today on a recent research report from John Hopkins Children’s Center in the peer-reviewed publication Nature journal Communications Biology1. Data generated by the … [Read more…]

QuidelOrtho to participate in the William Blair 42nd Annual Growth Stock Conference June 8, 2022 SAN DIEGO–(BUSINESS WIRE)–QuidelOrtho Corporation (NASDAQ: QDEL) (“QuidelOrtho”) announced completion of the transaction combining Quidel Corporation (“Quidel”) and Ortho Clinical Diagnostics Holdings plc (“Ortho”), creating QuidelOrtho, a leading in vitro diagnostics company. The new company, headquartered in San Diego, California, generated … [Read more…]

Advanced Insights and Analysis into Emerging and Developing Global Animal Health Needs to Better Support Prediction and Prevention Efforts NEW YORK–(BUSINESS WIRE)–NWO.ai, a leading strategic intelligence platform that is revolutionizing the future of external data for enterprises, today announced that it has exclusively partnered with Boehringer Ingelheim, a global leader in the animal health industry. … [Read more…]

GUANGZHOU, China–(BUSINESS WIRE)–LintonPharm Co., Ltd., a China-based biopharmaceutical company focusing on the development of T cell engaging bispecific antibodies for cancer immunotherapy, announces that preliminary results of Catumaxomab for advanced Gastric Cancer (GC) with peritoneal metastasis is published online at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting. Abstract Number：e16102 Abstract Title：Global multi-center … [Read more…]

OXFORDSHIRE, England & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Oak Hill Bio (“Oak Hill”), a clinical-stage neonatology and rare disease therapeutics company developing life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases, today announced that members of its senior leadership team will participate in virtual one-on-one meetings with investors at the upcoming 2022 Wells Fargo … [Read more…]

SANTA CLARA, Calif.–(BUSINESS WIRE)–Agilent Technologies Inc. (NYSE: A) today announced a collaboration agreement with APC Ltd., in which the companies commit to working towards combining their technologies to provide unique workflows to customers that support automated process analysis via liquid chromatography (LC). Agilent has selected to partner with APC, a provider of innovative small molecule … [Read more…]

Mercy Halo Data Demonstrates Promise of Novel Extracellular Vesicle Biomarker-Based Approach for Early Cancer Detection NATICK, Mass.–(BUSINESS WIRE)–#asco—Mercy BioAnalytics, Inc., a pioneer in extracellular vesicle-based liquid biopsies for the early detection of cancer, today announced that the Mercy Halo Ovarian Cancer (OC) assay substantially outperformed CA125 when distinguishing patients with early-stage high-grade serious ovarian cancer … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Asia Pacific Preoperative Infection Prevention and Wound Cleansing Device Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product, Surgery and Application” report has been added to ResearchAndMarkets.com’s offering. Asia Pacific Preoperative Infection Prevention and Wound Cleansing Devices Market for Cosmetic Surgery Segment to Grow Significantly During 2021-2028 Asia Pacific … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “North America Cardiac Monitoring Devices Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type; Product Type, Application and End User” report has been added to ResearchAndMarkets.com’s offering. Cardiovascular Devices Segment to Lead Cardiac Monitoring Devices Market During 2021-2028 The North America cardiac monitoring devices market is expected to reach … [Read more…]

This is the second consecutive year that Castle has been recognized for its innovative solutions in dermatology FRIENDSWOOD, Texas–(BUSINESS WIRE)–$CSTL #CSTL–Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it has been selected as the winner of the “Best New Technology Solution – Dermatology” award … [Read more…]